OMIKRON Database · Open Submission

Contribute to
OMIKRON
V20

Every published paper carries data the world hasn't indexed yet.
Send it to us — we do the rest.

OMIKRON is a cross-domain knowledge database spanning oncology, biophysics, molecular biology and clinical protocols. It is the computational backbone of the Logikron Rescued Oncology Assets framework. Every new record expands the network — and the network is the intelligence.
Submit Your Paper ↓
20,147 Total Records · V20
48 Dataset Codes
1,884 Cross-Domain Connections
91.6 Avg Consensus Score
0 Community Submissions
How It Works

Four steps. One email.

No forms. No accounts. No bureaucracy. Send the paper — we handle indexing, validation and ID assignment.

01 — SEND
Email Your Publication
Send your published paper (DOI or PDF) to info@logikron.org with the subject line OMIKRON Submission. Any oncology, biophysics, molecular biology or clinical paper is eligible. Preprints are accepted.
02 — EXTRACT
We Index the Records
The Logikron team extracts all relevant records from your paper, maps them to the correct dataset codes, assigns consensus scores, and stores your DOI as the primary source field of every extracted record.
03 — VALIDATE
Quality & Coherence Check
Each record is validated against the OMIKRON V20 ontology: physical coherence within the FDO framework, biological plausibility, cross-domain connection mapping, and scoring against existing records in the database.
04 — RETURN
You Receive Your IDs
Within 10 business days you receive a notification listing all assigned OMIKRON record IDs — one per extracted record — plus a brief descriptive summary of how each record was indexed and which dataset it was assigned to.
📬
For each submitted paper you receive a unique OMIKRON record code per extracted record, along with a descriptive note explaining the dataset assignment and cross-domain connections identified.
OF000001 · OF000002 · OF000003 …
Why Contribute

Your data doesn't disappear.
It becomes infrastructure.

Every record you contribute strengthens the network that identifies Rescued Oncology Assets — and places your work at the center of it.

🔗
Permanent DOI Linkage
Your paper's DOI is stored as the primary source field of every record extracted from it. Every future query that retrieves those records traces back directly to your publication.
🆔
Official OMIKRON IDs
Each extracted record receives a permanent OMIKRON identifier (OF______). You can cite these IDs in supplementary materials, data availability statements and future publications.
🌐
Cross-Domain Visibility
OMIKRON connects oncology, biophysics, clinical protocols and pharmacology. Your paper may generate connections to records in entirely different domains — expanding its scientific reach beyond its original field.
📈
Network Effect
The more records OMIKRON contains, the more powerful the Rescued Oncology Asset identification engine becomes. Your contribution directly improves the quality of every future Drug Intelligence Report generated by the platform.
🔓
Open Standard
The OMIKRON record format is an open standard. No proprietary lock-in. Your data remains yours — we index it, we do not own it. Attribution is always preserved and traceable.
🏛️
Become Part of the Reference
OMIKRON is designed to become the cross-domain reference database for drug repurposing in oncology — analogous to what PDB is for structural biology or GEO for genomics. Early contributors shape the standard.
Dataset Glossary

48 Dataset Codes · OMIKRON V20

Every record belongs to one of these 48 datasets. When you submit a paper, we identify which datasets your records map to and explain the assignment in the return notification.

🔍

Showing 48 of 48 datasets

Physical Framework
FL
Framework Laws
Fundamental physical laws of the OMIKRON system. FL records are the axioms of the FDO (Forced Damped Oscillator) framework. Highest epistemic priority in the database.
FD
Framework Definitions
Operative definitions of the core physical parameters of the database. The foundational physical vocabulary underpinning all quantitative records.
FR
Framework Rules
Operative rules derived from FL laws. Includes the core predictive relationships and the clinical thresholds for therapeutic intervention defined by the framework.
FP
Framework Predictions
Falsifiable predictions derived from the FDO framework. Records that bridge the physical model to measurable clinical endpoints and testable biological hypotheses.
FX
Framework Extensions
Extensions of the FDO framework into non-oncological domains: neurology, cardiology and general pharmacology. All records maintain the core FDO structure.
Oscillators, Hubs and Biological Networks
AX
Axis Records
Foundational records of the principal biological axes: AVB axis, HPA axis, microbiota-gut-brain axis. The largest dataset in OMIKRON — the structural backbone of the database.
HX
Hub Extended
Extended records of the 7 OMIKRON cybernetic hubs: Metabolic, Bioelectric, Immune, ECM, Neural, Microbiome and Endocrine. Includes inter-hub relationships and cross-hub signalling.
HB
Hub Baseline
Baseline definition records for the 7 cybernetic hubs. The essential version of HX — the fundamental nodes before extensions and inter-hub mapping.
QX
Quantum Extended
Records from the QUANTUM_THERMO domain: ionic oscillators, polaritonic coupling, phonons and quantum membrane states. Includes the hybrid quantum-mechanical oscillator model.
GX
Genomic Extended
Advanced genomic records: resonance-based screening, driver mutation networks and oncogenic network topology as interpreted through the FDO framework.
GR
Genomic Resilience
Records on genomic resilience: existential value vectors, cellular survival mechanisms and structural anti-apoptotic pathways modelled within the FDO framework.
Oncological Molecular Biology
BB
Biomarker Bank
Oncological biomarker repository: gene amplifications, point mutations, protein expression profiles and genomic signatures. Primary dataset for patient stratification and subcohort selection.
BX
Biomarker Extended
Extended biomarkers with functional context: ferroptosis pathways, oxidative stress mechanisms and tumor metabolic profiles. Covers emerging vulnerability markers beyond classical genomic signatures.
DX
Driver Extended
Records on oncogenic driver mutations: epigenetic silencing, key oncogenic pathways (BRAF, KRAS, EGFR, ALK) and the molecular mechanisms of neoplastic transformation.
KX
Kinase Extended
Records on kinase pathways: DNA damage response (DDR), DNA repair deficiency and oncogenic phosphorylation networks. Key dataset for synthetic lethality pairing.
CC
Cell Cycle
Cell cycle records: CDK inhibition, G1/S/G2/M checkpoint dynamics and cell cycle progression modelled as damped oscillation within the FDO framework.
CL
Cell Ligand
Records on receptor-ligand complexes: integrin complexes and membrane-ECM interactions relevant to drug delivery and mechanosensory signalling.
MX
MicroRNA Extended
Records on oncogenic microRNAs and circular RNAs: post-transcriptional silencing mechanisms and RNA-based regulation of oncogenic networks.
OX
Oncogene Extended
Records on specific oncogenes and their activation mechanisms: histone modifications and chromatin remodelling events that drive oncogenic gene expression programs.
Drugs, Therapies and Clinical Trials
CP
Clinical Pipeline
Records of drugs currently in clinical pipeline: acquired resistance mechanisms, novel molecules in Phase 1–3 and active trial evidence. Directly feeds the Rescued Oncology Asset screening process.
LX
Literature Extended
Records from extended clinical literature: published trials and peer-reviewed studies providing Level 1–2 evidence for approved or approval-stage drug combinations.
SH
Synthetic Hub
Records of applied synthetic lethality: synergistic drug combinations validated in vitro and in vivo. Core dataset for the SL Mapping step of the Logikron pipeline.
TK
Tyrosine Kinase
Records specific to tyrosine kinase inhibitors (TKI): resistance mechanisms, optimal administration sequences and TKI interactions with DDR and immune checkpoint pathways.
SX
Strategy Extended
Advanced therapeutic strategy records: toxicity redirection approaches and therapeutic window optimization strategies derived from the FDO physical model.
NX
Network Extended
Oncological network medicine records: immune checkpoint inhibitor synergies, network feedback loops and cybernetic signalling dynamics within the tumor microenvironment.
IX
Interaction Extended
Pharmacological interaction records: pharmacokinetic wave overlap and PK/PD interactions modelled within the FDO framework as coupled oscillatory systems.
XD
Cross-Domain
Explicitly cross-domain records that serve as bridges between biological and physical domains. Dedicated dataset for inter-domain connections identified by the OMIKRON engine.
Clinical Protocols, Safety and BPS
TX
Theoretical Extensions
Theoretical formalizations of the FDO framework: hydraulic impedance, oncogenic pressure, systemic damping and thermodynamic decompression models. Includes the 7-hub OMIKRON architecture.
VX
Vector Extended
ECM and microenvironment intervention vectors: microfluidic payloads, LOX inhibitors, normalizing anti-VEGF agents and matrix softening strategies for TME restoration.
WX
Wireless Expert / Signal Recovery
Signal recovery and coupling restoration records. WX represents the therapeutic signal successfully reaching its target — the endpoint of TME normalization within the OMIKRON framework.
UCB
Upfront Combinatorial Blockade
Taxonomy and clinical cases of upfront combinatorial blockade: Vertical Inhibition (VI), Horizontal Inhibition (HI) and Convergent Node Inhibition (CNI) with landmark trial references.
BPS
Biological Pulse Sequences
Time-structured therapeutic protocols modelled on NMR pulse sequence logic. The oncological equivalent of pulse sequences — defining timing parameters for multi-agent administration schedules.
PX
Protocol Precautions
Safety constraints and protocol precautions: timing paradoxes, controlled softening gradients and pre-administration checklists. The operational safety layer of the OMIKRON protocol system.
Microenvironment, Immunity and Pathophysiology
CX
Clinical Extended
Extended clinical records: bleeding risk profiles, adverse events, toxicity patterns and clinically relevant drug interactions mapped within the OMIKRON safety framework.
SW
Software / Systems
Computational analysis records: image analysis systems, scoring algorithms and computational network analysis tools applied to oncological data within the OMIKRON architecture.
TM
Tumor Microenvironment
Tumor microenvironment records: gut microbiome composition, microbiota-immune-TME axis dynamics and the role of bacterial metabolites in modulating the tumor microenvironment.
SY
Systemic Axes
Non-oncological systemic axis records: the Amygdala-Vagal-Brunner (AVB) axis, neuro-visceral regulation and the stress-immune-TME interface as modelled in the FDO framework.
PP
Pathophysiology Plus
Extended pathophysiology records toward neurological domains: protein aggregation mechanisms and neurodegeneration pathways interpreted through the FDO oscillatory framework.
ST
Systemic Targets
Special systemic target records: blood-brain barrier permeability modelling, CNS targeting strategies and pharmacological agents with demonstrated BBB penetration.
OS
Off-System
Records outside the primary oncological system: bacterial mimetic peptides and infection immunology applied within the broader OMIKRON framework.
DERM
Dermatology Extended
Dermatological endocrinology records: the hyperinsulinemia-IGF1 axis in skin pathology and cutaneous tumors, modelled as a peripheral oscillatory system within the FDO framework.
Special Records and Singletons
MX*
Mechanomutation Extended
MX dataset in the OMIKRON-2026 sense (distinct from MicroRNA MX): isomechanical homing, nuclear deformation-driven mutation and Impedance Jamming Therapy. Frontier records at the physics-oncology boundary.
SH*
Special Hub / Safety Records
SH dataset in the original sense: Safety Hub. Therapeutic safety records including validated synergistic combinations and safety boundary definitions for multi-agent protocols.
⬡ The database has grown organically — some dataset codes (e.g. MX, FD) carry overlapping meanings for historical reasons. Semantic coherence is guaranteed by the internal Database field (e.g. OMIKRON_BPS_PROTOCOLS, OMIKRON_BPS_SAFETY), which is more precise than the ID prefix alone. Version V20 · 20,147 records · June 2026.
Submit Now

Add your paper
to the database

Send your published paper to the address below.
Use the exact subject line shown — it routes your submission automatically.
No forms. No accounts. Just the paper.


Open Email Client →

Include the DOI or PDF of your paper  ·  Any language accepted  ·  Preprints eligible
You will receive your OF______ record IDs within 10 business days

OMIKRON V20 · 20,147 records · 48 dataset codes · June 2026
For research use only · KRONOMED SRL · Confidential · REP-DR-001